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Background: The second-generation drug-eluting stents (DES) have a upgraded stent platform with improved conformability compared to the first-
generation DES (Cypher Bx®, Taxus Express®). While the incidence, predictors and clinical outcomes of stent fracture (SF) of the first-generation DES 
are relatively well known, those of the second-generation DES have not been studied. We identified incidence, predictors and clinical outcomes of SF 
of the second generation DES, such as Cypher Select® (CS), Taxus Liberte® (TL) and Endeavor® (EN). 
Methods: Clinical and angiographic records of patients who received percutaneous coronary intervention and follow-up coronary angiography 
(CAG) were retrospectively analyzed in 5 medical centers from May-2005. 
Results: Of 1156 lesions analyzed, 635 lesions were implanted with CS, 411 lesions with TL and 110 lesions with EN. Total 14 SF were found at 
follow-up CAG. The occurrences of SF were similar between stent type (Total 1.21% [14/1156]: CS 1.57% [10/635], TL 0.97% [4/411], EN 0% 
[0/110], p=0.41). SF exclusively occurred in the left anterior descending artery (60%) and right coronary artery (40%). Patients with SF showed 
higher incidence of B2/C lesions (100% vs 69.4%, p=0.002), smaller reference vessel diameter (3.17±0.3mm vs 3.35±0.4mm, p=0.01), longer 
lesion length (37.2±18 mm vs 23.5±11 mm, p=001), longer total stent length (36±19mm vs 24±11mm, p=0.03) than those without SF. Although 
binary restenosis occurred infrequently in all patients with DES (6.9%), patients with SF frequently developed binary restenosis (patients with SF 
[21.4%] vs without SF [6.3%], p=0.026). However, the rate of target lesion revascularization did not differ (patients with SF [14.3%] vs without SF 
[5.9%], p=0.2). Total stent length was the only significant independent predictor of SF (odds ratio 1.06, 95% CI: 1.03-1.09, p<0.001). 
Conclusions: The introduction of upgraded stent platforms may reduce the incidence of SF in the second-generation DES. However, when SF 
occurs, the occurrence probability of restenosis is still high.
